|
|
||||||||
Department of Human Anatomy and Cell Biology, University of Liverpool, Liverpool L69 3GE, United Kingdom
| |
ABSTRACT |
|---|
|
|
|---|
Mitochondrial Ca2+ uptake is
usually thought to occur only when intracellular Ca2+
concentration ([Ca2+]i) is high. We
investigated whether mitochondrial Ca2+ removal
participates in shaping [Ca2+]i signals in
arterial smooth muscle over a low [Ca2+]i
range. [Ca2+]i was measured using fura
2-loaded, voltage-clamped cells from rat femoral arteries. Both
diazoxide and carbonyl cyanide m-chlorophenylhydrazone (CCCP) depolarized the mitochondria. Diazoxide application increased resting [Ca2+]i, suggesting that
Ca2+ is sequestered in mitochondria. Over a low
[Ca2+]i range, diazoxide and CCCP slowed
Ca2+ removal rate, determined after a brief depolarization.
When [Ca2+]i was measured during sustained
depolarization to
30 mV, CCCP application increased
[Ca2+]i. When Ca2+ transients
were repeatedly evoked by caffeine applications, CCCP application
elevated resting [Ca2+]i. Caffeine-induced
Ca2+ transients were compared before and after CCCP
application using the half decay time, or time required to reduce
increase in [Ca2+]i by 50%
(t1/2). CCCP treatment significantly
increased t1/2. These results suggest
that Ca2+ removal to mitochondria in arterial smooth muscle
cells may be important at a low [Ca2+]i.
carbonyl cyanide m-chlorophenylhydrazone; diazoxide; fura 2; rhodamine 123; sarcoplasmic reticulum
| |
INTRODUCTION |
|---|
|
|
|---|
UNTIL RECENTLY, mitochondrial Ca2+ uptake was thought to occur only when cytosolic Ca2+ concentration ([Ca2+]i) became abnormally high. However, this traditional view is now being questioned. Several reports (7, 16, 34) provided strong evidence that mitochodria are an integral part of Ca2+ regulatory mechanisms in a variety of cell types. The key to the reevaluation of the role of mitochondria was the development of the two mitochondria-specific Ca2+-sensitive indicators recombinant aequorin and rhod 2. Rizzuto et al. (36) genetically engineered mitochondria-targeted aequorin and reported that Ca2+ in mitochondria is elevated during the generation of inositol 1,4,5-trisphosphate, a ubiquitous second messenger that releases Ca2+ from intracellular stores (35). Similarly, rhod 2, a positively charged Ca2+-sensitive dye that tends to accumulate into mitochondria, permitted direct detection of mitochondrial Ca2+ concentration changes in a wide range of cells (2, 6, 17, 31). These studies often suggested that mitochondria do not simply lower [Ca2+]i but modulate other Ca2+ regulatory mechanisms (7, 16, 34). In particular, one recurring theme is that mitochondria seem strategically positioned near the origin of Ca2+ sources and thus can sense localized Ca2+ changes. In turn, Ca2+ removal to neighboring mitochondria may modulate the behavior of Ca2+ permeable channels through feedback mechanisms (22). The hypothesis that mitochondria are positioned close to Ca2+ sources is also useful in explaining why mitochondria, thought to have low affinity for Ca2+, can sequester Ca2+ in the absence of very high [Ca2+]i. The complexity of the role of mitochondria, however, may mean that results obtained from one cell type may not be applicable to others where intracellular architecture or [Ca2+]i raising mechanisms are different. To date, relatively few studies (6, 31) have addressed the role of mitochondrial Ca2+ uptake by using arterial smooth muscle cells. Furthermore, increases in [Ca2+]i required to induce maximum contraction in arteries may be rather modest (29); yet to our knowledge, few studies so far examined Ca2+ uptake by mitochondria at a lower range of [Ca2+]i. Monteith and Blaustein (31) reported that a moderate increase in [Ca2+]i does not produce marked Ca2+ changes in the majority of mitochondria with the use of cultured rat aortic smooth muscle cells. Also, using rat pulmonary artery smooth muscle cells, Drummond and Tuft (6) reported elevation in mitochondrial Ca2+ when [Ca2+]i was raised to ~1 µM, a concentration perhaps rarely experienced under normal conditions.
The current study examines the role of mitochondria in Ca2+ handling in arterial smooth muscle cells. Ca2+ removal was studied using voltage-clamped single arterial smooth muscle cells dialyzed with the Ca2+-sensitive dye fura 2. Ca2+ transients were evoked by Ca2+ influx or Ca2+ release, and the effect of agents thought to prevent mitochondrial Ca2+ uptake was studied. Also, changes in mitochondria membrane potential were detected using rhodamine 123, and effects of drugs thought to modify mitochondrial potential were investigated. Our results suggest that mitochondrial Ca2+ uptake is activated during Ca2+ influx and Ca2+ release. Ca2+ sequestration to mitochondria seems to occur even when the elevation in [Ca2+]i is modest. In the presence of putative inhibitors of mitochondrial Ca2+ uptake, the Ca2+ removal rate over the lower range of [Ca2+]i was reduced. Moreover, the results suggest that Ca2+ content in mitochondria may influence Ca2+ load in the sarcoplasmic reticulum. Part of this study has been presented as an abstract (26).
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Cell preparation. Male Sprague-Dawley rats (200-300 g) were made unconscious by exposure to an increasing concentration of CO2, and then euthanized by exsanguination in accordance with Schedule 1 of the Animals (Scientific Procedures) Act, 1986. The femoral arteries were dissected in a salt solution containing (in mM) 137 NaCl, 0.44 NaH2PO4, 0.42 Na2HPO4, 4.17 NaHCO3, 5.6 KCl, 1 MgCl2, 2 CaCl2, 10 HEPES, and 10 glucose (pH adjusted to 7.4 with NaOH) (23). Single smooth muscle cells were enzymatically dissociated in a low-Ca2+ salt solution containing (in mM) 80 Na glutamate, 55 NaCl, 6 KCl, 2 MgCl2, 0.2 CaCl2, 10 HEPES, 10 glucose, and 0.2 EDTA (pH was adjusted to 7.3 at room temperature so that at 35°C, it will be 7.4) (23). At 35°C, the femoral artery was first digested for 30 min with 1.7 mg/ml papain and 0.7 mg/ml dithioerythritol and then for 20 min with 1.7 mg/ml collagenase (type F) and 1 mg/ml hyaluronidase (type I-S). Single smooth muscle cells were obtained by triturating the artery with a fire-polished Pasteur pipette. The cell suspension was kept in a refrigerator at 2-8°C, and all experiments were carried out on the same day.
Electrophysiology and microfluorimetry.
Voltage clamp was achieved using a conventional whole cell clamp
technique (18). Under control conditions, the
extracellular solution was composed of (in mM) 80 Na glutamate, 40 NaCl, 20 tetraethylammonium Cl, 1.1 MgCl2, 3 CaCl2, 10 HEPES, and 30 glucose (pH 7.4 with NaOH). The
intracellular solution consisted of (in mM) 145 CsCl, 3 MgCl2, 3 Na2ATP, 10 HEPES, and 0.05 fura 2 pentapotassium (pH 7.2 with CsOH). Membrane currents were amplified
using Axopatch 200B (Axon Instruments), filtered at 1 kHz, and sampled
at 5 kHz using pCLAMP version 7 software (Axon Instruments). Stock
solutions of all test drugs except caffeine were made with DMSO at
1,000-fold of final concentrations. All agents except caffeine were
applied by perfusing the experimental chamber with appropriate bath
solutions. An elevation in [Ca2+]i was
induced by Ca2+ influx through voltage-dependent
Ca2+ channels or by Ca2+ release from the
sarcoplasmic reticulum. Ca2+ channels were activated either
by 1.8-s depolarization to 0 mV from a holding potential of
70 mV or
by sustained depolarization to
30 mV. Ca2+ release was
triggered by rapid application of 20 mM caffeine using a U tube
superfusion system (9). In this case, a cell was voltage
clamped at
70 mV, and the U tube with a small hole in its apex was
placed in close proximity. The bath solution was continuously perfused
while caffeine-containing bath solution was run through the U tube.
Outflow of the U tube was made larger than inflow. In this arrangement,
caffeine-containing solution does not leak out from the hole. Outflow
was fed through a solenoid valve before being finally discarded. When
the valve is closed, the caffeine-containing solution is promptly
ejected from the hole in the U tube, producing a caffeine concentration
jump. The cell remains exposed to caffeine as long as the valve is
closed. When the valve is reopened, the caffeine-containing solution
resumes to run to waste, whereas caffeine in the experimental chamber is washed out. The valve was controlled by pCLAMP command.
[Ca2+]i was measured with deltaRAM (Photon
Technology International), as previously described (23). A
single cell was alternately illuminated with UV light of 340 and 380 nm
(bandpass 8 nm) at 100 Hz. Emission signals were detected at 510 nm
(bandpass 40 nm). The dissociation constant (Kd)
for fura 2 was calculated as 180 nM from in vitro calibration using
intracellular solutions containing a range of known free
Ca2+. The desired free Ca2+ was
produced by adding required amount of CaCl2, calculated
with software (Buffer version 1.0; Dr. R. Schubert, Universität
Rostock, Germany), to 10 mM EGTA-buffered pipette solution. The
fluorescence ratios in the absence of added CaCl2
(Rmin) and in the presence of saturating Ca2+
(Rmax) were determined from in vitro measurements.
Conversion of ratios (R) to [Ca2+]i was
carried out using the equation
Kd(F0/Fs)(R
Rmin)/(Rmax
R), where F0 is
the count at 380 nm with Rmin solution and Fs is that with Rmax solution (15, 33).
Rmin and Rmax were decreased by 15% to adjust
for viscosity (33). Background signal was measured for
each cell after formation of a gigaohm seal and before formation of
whole cell clamp mode. To measure mitochondrial membrane potential, cells were loaded with rhodamine 123 (10 µg/ml) for 10-15 min at
room temperature (8). Cells were rinsed with dye-free
solution consisting of (in mM) 80 Na glutamate, 55 NaCl, 6 KCl, 2 MgCl2, 0.2 CaCl2, 10 HEPES, and 10 glucose (pH
7.4 with NaOH). Cells were not voltage clamped in these experiments.
The fluorophore was excited at 500 nm (25 nm bandpass), and emission
signal was determined at 545 nm (35 nm band pass) with a frequency of
10 Hz. Rhodamine 123 signals were expressed as the relative
fluorescence intensity against the photon counts at the beginning of
experiments. Data were expressed as means ± SE of n
cells. When appropriate, Student's paired t-test or one-way
ANOVA, followed by Tukey's test as a post hoc analysis, was used to
evaluate significant difference. All experiments were carried out at
room temperature.
Drugs. Fura 2 pentapotassium salt and rhodamine 123 were purchased from Molecular Probes. Cyclopiazonic acid (CPA) was obtained from Calbiochem-Novabiochem. Diazoxide was purchased from Research Biochemicals International. Papain was obtained from Worthington Biochemical. All other agents were from Sigma or BDH.
| |
RESULTS |
|---|
|
|
|---|
Ca2+ removal profile of rat femoral
artery smooth muscle cells.
To investigate Ca2+ regulatory mechanisms,
voltage-dependent Ca2+ channels were activated by
depolarization to 0 mV from a holding potential of
70 mV (Fig.
1A, third trace). This
maneuver evoked Ca2+ current (Fig. 1A, second
trace) and elevated [Ca2+]i (Fig.
1A, first trace). On repolarization to
70 mV, increased [Ca2+]i returned to the resting level,
allowing the examination of Ca2+ clearance (23,
25). A high-order polynomial equation was fitted to the
declining phase of the Ca2+ transient, and Ca2+
removal rate was calculated as the negative derivative of the fit. The
result is expressed as either a function of the measured [Ca2+]i (Fig. 1A, fourth trace,
left) or time where time 0 is the instance of
repolarization (Fig. 1A, fourth trace, right).
These traces (Fig. 1A, fourth trace, left and
right) exemplify a complex waveform obtained in about one-half of
the control cells. In these cells, the Ca2+ removal was
initially fast over higher [Ca2+]i but
decreased as [Ca2+]i declined. Just before
elevated [Ca2+]i returned to the resting
level, however, an increase in Ca2+ removal occurred,
appearing as an upward hump in the removal profile. This shape of
Ca2+ clearance may be termed as "peak-trough-peak," or
phase 1, phase 2, and phase 3 (23, 25, 30). Phase 3, a delayed increase in
Ca2+ removal rate, was absent (Fig. 1B, fourth
trace, left and right) in about one-half of the control
cells. In the control cells that lack phase 3, raised
[Ca2+]i seems to recover quickly (Fig.
1B, first trace). These two types of Ca2+
removal pattern will be further discussed later.
|
Mitochondrial Ca2+ sequestration
examined by diazoxide application.
The importance of mitochondria in Ca2+ regulation has now
been acknowledged in many cell types (7, 16, 34), but
their role in arterial smooth muscle remains unclear. First, we sought to establish that Ca2+ is indeed sequestered in
mitochondria. Because Ca2+ is sequestered in mitochondria
by virtue of negative potential in mitochondrial inner membrane
(7, 16, 34), the agents that depolarize mitochondria
should discharge stored Ca2+. We used 100 µM diazoxide to
depolarize mitochondria. Although its mechanism has yet to be fully
established, there is evidence showing that, in cardiac myocytes,
diazoxide depolarizes mitochondria and raises
[Ca2+]i (see DISCUSSION). When
diazoxide was applied to the cells voltage clamped at
70 mV,
elevation in [Ca2+]i was not always observed.
This may not be surprising because without prior stimulation,
Ca2+ in mitochondria is probably not much higher than
[Ca2+]i (31). Therefore, the
cells were subjected to a brief depolarization to evoke a
Ca2+ transient before the application of diazoxide. The
Ca2+ efflux from the mitochondria may be a slow process in
smooth muscle cells (6), and thus Ca2+ in
mitochondria may remain elevated even when the global
[Ca2+]i is already returned to the resting
level (6). Figure 2 shows one such experiment. [Ca2+]i was first raised
by depolarization (Fig. 2, left). Subsequent diazoxide
application elevated [Ca2+]i, whereas the
membrane potential was maintained at
70 mV (Fig. 2,
right). The time gap between the left trace and the right
trace in Fig. 2 was ~30 s. Diazoxide-induced elevation in
[Ca2+]i was observed in all cells subjected
to prior voltage pulse, with an average
[Ca2+]i increase of 90 ± 20 nM
(n = 7). The results suggest that mitochondria can in
fact accumulate Ca2+ during Ca2+ influx and
their Ca2+ remains sufficiently high even after global
[Ca2+]i returned to the resting level.
|
Ca2+ removal profile determined in
the presence of mitochondrial depolarizing agents.
When depolarized, mitochondria no longer sequester Ca2+ due
to the diminished driving force on Ca2+. Thus the
Ca2+ removal profile was examined in the presence of 100 µM diazoxide. When [Ca2+]i was raised by
depolarization (Fig. 3A, third
trace), it returned to the resting level slowly (Fig. 3A,
first trace) without the upward hump in the Ca2+ removal
profile (Fig. 3A, fourth trace). Similar results were obtained from four other cells. The inhibition of phase 3 in
the diazoxide-treated cells is somewhat different from that in the control cells without phase 3. As shown in toad stomach
cells (30), phase 3 occurs in femoral artery
smooth muscle cells only when [Ca2+]i is
elevated for long enough (23). After depolarization, the average time required to restore resting
[Ca2+]i in the control cells with phase
3 was 49.9 ± 7.7 s (n = 7), whereas
that of the control cells without phase 3 was 18.7 ± 2.7 s (n = 6). On the other hand, the average time
required to restore basal [Ca2+]i in
diazoxide-treated cells was 54.8 ± 10.2 s (n = 5). This seems long enough to evoke the delayed acceleration in
Ca2+ removal, yet phase 3 was largely
diminished.
|
Effect of mitochondrial depolarizing agent on steady-state [Ca2+]i. The inhibitory effect of diazoxide and CCCP on phase 3 over lower [Ca2+]i was surprising because mitochondria are generally thought to sequester Ca2+ when [Ca2+]i is high (31). Because the Ca2+ removal rates were examined after a large depolarizing pulse, it is possible that the putative mitochondrial role in Ca2+ clearance may be exaggerated. Unlike neurons or cardiac myocytes, many smooth muscle cells, including those from femoral arteries, do not fire action potential. Rather, stimulation produces smaller and sustained depolarization. During continued depolarization, a new level of [Ca2+]i is achieved, reflecting an altered balance between Ca2+ influx and Ca2+ removal. Previous studies (10, 24) showed that [Ca2+]i increased by ~100 nM during sustained depolarization. If mitochondrial Ca2+ uptake is important only when [Ca2+]i is raised sufficiently high, inhibition of mitochondrial Ca2+ removal would have little impact on steady-state [Ca2+]i. On the other hand, if mitochondrial Ca2+ clearance is also important over lower [Ca2+]i, steady-state [Ca2+]i may be affected by mitochondrial Ca2+ uptake inhibitors.
We examined the effect of CCCP on steady-state [Ca2+]i increase produced by constant depolarization. Figure 4 shows one such experiment. Membrane potential was gradually increased from
70 mV to
50 mV to
30 mV (Fig. 4, bottom trace), producing a slow and steady [Ca2+]i increase (Fig. 4,
top trace). When 1 µM CCCP was applied (downward arrow)
while the membrane potential was maintained at
30 mV, an increase in
[Ca2+]i was observed. This elevation in
[Ca2+]i was partially reversible after
perfusion with CCCP-free bathing solution (upward arrow). Though the
magnitude of [Ca2+]i increase was variable
among cells, CCCP application elevated [Ca2+]i in all six cells tested with the
average maximum increase of 280 ± 180 nM (n = 6).
These results suggest that mitochondrial Ca2+ removal
participates in shaping steady-state [Ca2+]i
during sustained depolarization.
|
Effect of mitochondrial depolarizing agent on caffeine-induced
Ca2+ transient.
When mitochondria act as a Ca2+ buffer, their location
within the cell may be important. For example, Park et al.
(32) have reported that the origin of Ca2+
influences which mitochondria, perinuclear, perigranular, or subplasmalemmal, will preferentially remove Ca2+ in
pancreatic acinar cells. In arterial smooth muscle cells, elevation in
[Ca2+]i may occur not only due to
Ca2+ influx but also Ca2+ release from the
sarcoplasmic reticulum. The results described so far show mitochondrial
Ca2+ clearance after Ca2+ influx. This does not
mean that mitochondrial Ca2+ uptake is also important when
Ca2+ is released. Therefore, we examined the effect of CCCP
on caffeine-induced Ca2+ transients. Caffeine is one of the
standard agonists for sarcoplasmic reticulum Ca2+ release
because it activates ryanodine receptors. While cells were being
voltage clamped at
70 mV, 20 mM caffeine was applied for 1 s
with the U tube superfusion system, as described in MATERIALS AND
METHODS. This arrangement permitted reproducible caffeine-induced Ca2+ transients. Figure
5A shows one such experiment
under control conditions. The solid squares below the
[Ca2+]i trace indicate application of 20 mM
caffeine. The duration of caffeine transients was somewhat variable
among cells, probably reflecting variable efficiency of the drug
washout. Nonetheless, Ca2+ transients obtained from the
same cell were reproducible. For analysis purposes (see below), we
discarded the first transient and used second, third, and sometimes
fourth Ca2+ transients because in some cells the first
Ca2+ transient was somewhat different from the rest.
|
Modulation of mitochondrial membrane potential.
The results described above attempted to dissect mitochondrial
contribution to Ca2+ homeostasis with the use of
pharmacological interventions. CCCP and diazoxide were used to
inhibit mitochondrial Ca2+ uptake. It was assumed that both
agents prevent Ca2+ accumulation in the mitochondria by
depolarizing the mitochondrial membrane. While this assumption is
likely to be true for CCCP, a consensus regarding diazoxide actions is
yet to be achieved (see DISCUSSION). Therefore, we sought
evidence that both CCCP and diazoxide depolarized the mitochondrial
membrane. Cells were loaded with rhodamine 123, a positively charged
dye with a propensity to accumulate into mitochondria due to their
negative membrane potential (8). When concentrated above
threshold, quenching of the indicator occurs. On mitochondrial
depolarization, dye moves out from the organelles, relieving quench,
and thus increasing fluorescent signal. On the other hand,
mitochondrial membrane hyperpolarization will decrease fluorescence
intensity due to further concentration and thus quenching of the
fluorophore. In our experiments, the fluorescent signals declined
continuously, presumably due to dye bleaching and leaking. Nonetheless,
changes in the fluorescence intensity were detected on application of agents. As shown in Fig. 6A,
an application of CCCP (1 µM) produced an increase in fluorescent
signal, suggesting depolarization of mitochondria and subsequent dye
redistribution into the cytosol. This CCCP effect was reversible.
Diazoxide (100 µM), on the other hand, produced a small increase in
signal (Fig. 6B). This may not be surprising because the
half-maximum dose of diazoxide is 65-96 µM in cardiac
mitochondria (19), and thus 100 µM diazoxide is likely
to cause a partial depolarization. On the other hand, application of
CCCP is likely to cause near-complete depolarization of mitochondria.
When a higher concentration of diazoxide (500 µM) was tested, a
larger increase in fluorescence intensity was noted (Fig.
6C). We also examined the effect of oligomycin on rhodamine
123 fluorescence intensity. Unlike CCCP or diazoxide, oligomycin is
expected to cause a small hyperpolarization of mitochondria (8) (see DISCUSSION). Indeed, application of 3 µM oligomycin produced a small decrease in fluorescence intensity,
suggesting mitochondrial hyperpolarization (Fig. 6D). The
effect of oligomycin was not reversible (8). These
observations indicate that mitochondrial membrane potential is
depolarized by CCCP and diazoxide and hyperpolarized by oligomycin.
|
| |
DISCUSSION |
|---|
|
|
|---|
The main finding of the current study is that mitochondrial
Ca2+ removal occurs over a
[Ca2+]i range usually thought to be too low
for its action. When mitochondrial Ca2+ uptake was blocked
by diazoxide or CCCP, phase 3 of Ca2+ removal
corresponding to a lower range of [Ca2+]i was
inhibited. Also, during sustained depolarization to
30 mV where
[Ca2+]i increased modestly, application of
CCCP raised [Ca2+]i. These findings are
surprising because mitochondria are thought to sequester
Ca2+ when [Ca2+]i is high
(31). The [Ca2+]i corresponding
to phase 3 is low, and the primary candidate for
Ca2+ removal for this range of
[Ca2+]i would be ATP-fueled Ca2+
pumps. In fact, it was reported in a previous study (23)
on femoral artery smooth muscle cells that application of CPA, an inhibitor of the sarcoplasmic reticulum Ca2+ pump,
diminished phase 3. Likewise, application of thapsigargin or
ryanodine, both inhibitors of sarcoplasmic reticulum Ca2+
uptake, inhibited phase 3 in rat cerebral artery smooth
muscle cells (25). This raises the question as to why
mitochondrial Ca2+ uptake appears to operate over a
[Ca2+]i range, where excess Ca2+
is thought to be removed by the sarcoplasmic reticulum. One possibility is that diazoxide and CCCP reduced phase 3 by triggering
Ca2+-induced Ca2+ release (12).
Ca2+ discharge from mitochondria may activate ryanodine
receptors in the sarcoplasmic reticulum. This would render the
sarcoplasmic reticulum "leaky," effectively blocking
Ca2+ sequestration. However, this seems unlikely. Under
this scenario, the inhibition of sarcoplasmic reticulum
Ca2+ uptake would be transient. In the continuous presence
of diazoxide or CCCP, mitochondria are unable to sequester
Ca2+. Therefore, when Ca2+ discharge from
mitochondria is completed, the sarcoplasmic reticulum should resume
Ca2+ uptake. This was not the case. Another possibility is
that mitochondria depolarization deprived the Ca2+ pump in
the sarcoplasmic reticulum of ATP. The depolarized mitochondria may
rather consume than produce ATP in an attempt to restore membrane potential (5). Furthermore, even if more than enough
exogeneous ATP were available in the pipette solution, sarcoplasmic
reticulum Ca2+ pumps may require mitochondria-generated
"compartmentalized" ATP (37). To test this hypothesis,
the effect of the ATP synthase inhibitor oligomycin (3 µM) was
examined. Oligomycin blocks mitocondrial ATP production without
depolarizing mitochondria, thus keeping the mitochondrial ability to
sequester Ca2+ intact (5). Thus if oligomycin
also blocks phase 3, this would suggest that diazoxide and
CCCP indirectly inhibited the Ca2+ pump in the sarcoplasmic
reticulum. On the other hand, if Ca2+ removal in the
presence of oligomycin is more similar to that of the control, the
effect of diazoxide and CCCP is not due to ATP depletion. When
Ca2+ removal was examined in the presence of oligomycin,
phase 3 was not inhibited. Rather, Ca2+ removal
rate was faster in the presence of oligomycin at low [Ca2+]i. Figure
7 summarizes Ca2+ removal
rates determined in the presence of CCCP, diazoxide, CPA, oligomycin,
or no agent (control) at a [Ca2+]i of 75 nM.
A significant difference (P < 0.01) was detected between oligomycin data and CCCP, diazoxide, or CPA data using one-way
ANOVA, followed by Tukey's test for post hoc analysis. Interestingly,
a statistically significant difference was not detected between the
control cells and CCCP-, diazoxide-, or CPA-treated cells. This is
presumably because about one-half of the control cells did not develop
phase 3, as discussed earlier. The oligomycin effect was not
seen when the cells were also treated with CPA (n = 3, data not shown).
|
The results with oligomycin argue against the hypothesis that diazoxide and CCCP inhibited phase 3 by ATP depletion. Also, the apparent facilitation of Ca2+ removal by oligomycin is puzzling. Perhaps the hypothesis originally suggested using cardiac myocytes (4) and then the portal vein (12) that mitochondrial Ca2+ content influences sarcoplasmic reticulum Ca2+ load may be useful. If Ca2+ is initially stored in mitochondria and then shuttled to the sarcoplasmic reticulum, agents depolarizing mitochondria will inhibit sarcoplasmic reticulum Ca2+ uptake due to reduced Ca2+ supply. On the other hand, oligomycin hyperpolarizes mitochondria, increases Ca2+ content in mitochondria, and facilitates Ca2+ supply to the sarcoplasmic reticulum. The hyperpolarization caused by oligomycin is expected to be small because the effect of oligomycin is due to prevention of proton reentry into mitochondria, a process normally producing a small mitochondrial depolarization. This is in fact the case, as shown in Fig. 6. Nonetheless, the small hyperpolarization by oligomycin was sufficient to significantly promote Ca2+ removal.
There is no doubt that more work has to be carried out for final validation of the hypothesis that the Ca2+ content of mitochondria influences that of the sarcoplasmic reticulum. It is possible that data presented here are biased against the Ca2+ removal mechanisms requiring enzymes because all experiments were carried out at room temperature. Moreover, whether or not the mitochondria sequester Ca2+ when [Ca2+]i is raised by physiological agonists, such as adrenergic agents, needs to be addressed in a future study. Also, our study is solely based on temporal analysis of [Ca2+]i that provides no spatial information. In this regard, it is interesting to note that, using HeLa and HEK-293 cells expressing genetically engineered cameleon indicators, Arnaudeau et al. (1) recently provided evidence that Ca2+ reuptake to the endoplasmic reticulum is facilitated by Ca2+ efflux from the adjacent mitochondria. The conclusion offered by Arnaudeau et al. (1), that mitochondria promote endoplasmic reticulum Ca2+ uptake by providing Ca2+, not ATP, is also consistent with our findings. At the moment, the hypothesis that some Ca2+ is transferred from mitochondria to sarcoplasmic reticulum in the rat femoral artery seems best to reconcile our observations.
In light of its clinical importance (see below), the mechanism of diazoxide action on mitochondria merits further discussion. Diazoxide is probably best known as an opener of ATP-sensitive K+ (KATP) channels found not only in the plasma membrane (3) but also in mitochondrial membranes (21). More importantly, it has been suggested that the opening of mitochondrial KATP channels may confer resistance against ischemia to the heart. If the heart is subjected to mild ischemia, it becomes profoundly resistant against subsequent and more serious ischemic episodes (14), a phenomenon known as cardiac ischemic preconditioning. Interestingly, pretreatment with KATP channel openers seems to mimic the protective effect of the ischemic preconditioning (14). To date, however, beyond the notion that KATP channel openers exert preconditioning-like effects through mitochondrial rather than salcolemmal KATP channels, there is little consensus regarding this subject. Diazoxide has been useful in studying preconditioning because it selectively opens mitochondrial KATP channels (11). Although it seems logical to assume that activation of mitochondrial KATP channels will depolarize mitochondria (28), a recent report (13) suggested that diazoxide depolarizes mitochondria by inhibiting respiratory chain complex II, not by opening KATP channels. Our results seem to support this notion that in some cell types diazoxide depolarizes mitochondria independent of mitochondrial KATP channel opening. In this study, diazoxide triggered elevation in [Ca2+]i and inhibited the phase 3 Ca2+ removal when cells were dialyzed with Cs+. Under this condition, the opening of mitochondrial KATP channels seems unlikely to produce mitochondria depolarization. Likewise, Kowaltowski et al. (27) reported that replacement of K+ in mitochondria bathing medium with Li+, another poorly permeant ion to K channels, had little effect on diazoxide actions. It should be noted, however, that these authors ascribed cardioprotective effects of KATP channel openers to mitochondrial volume regulation, not to depolarization (27). These authors also reported few inhibitory effects of diazoxide on mitochondrial Ca2+ uptake (27). Our results, however, suggest that diazoxide depolarizes the mitochondrial membrane, discharges stored Ca2+ and modulates the Ca2+ removal profile. These discrepancies may be explained in part by the difference in experimental methods and materials.
One unresolved important question is how mitochondria sequester
Ca2+ over a low-[Ca2+]i range. In
particular, during sustained depolarization to
30 mV,
[Ca2+]i rarely reaches values high enough for
low-affinity Ca2+ removal mechanisms to be activated. One
possibility is that some mitochondria may be closely located to
Ca2+ channels, sensing higher Ca2+ than bulk,
averaged [Ca2+]i. This may, in turn, cause
mitochondria to modulate Ca2+ influx. If Ca2+
near the cell membrane is cleared by the mitochondria,
Ca2+-induced inactivation of voltage-dependent
Ca2+ channels will be suppressed. Indeed, Ca2+
influx regulation by mitochondria acting as a Ca2+ sink has
been suggested for Ca2+ channels in neurons
(5) and Ca2+ release-activated
Ca2+ channels in T lymphocytes (20).
In the present study, we provided evidence that mitochondria play an
important role in Ca2+ regulation using rat femoral
arterial smooth muscle cells. Mitochondrial Ca2+ clearance
seems important over lower [Ca2+]i range
because phase 3 was inhibited with mitochondrial
depolarizing agents. Moreover, steady-state
[Ca2+]i measured at a constant membrane
potential of
30 mV was elevated on addition of CCCP. Unlike cardiac
muscle, arteries do not generally fire action potentials and may
require a rather small increase in [Ca2+]i to
cause maximum contraction (29). Mitochondrial
participation in shaping [Ca2+]i during
sustained and modest depolarization, therefore, may have particular
relevance in arterial smooth muscle cells. Also, CCCP significantly
prolonged the duration of Ca2+ transients evoked by
caffeine application, implying a mitochondrial role in Ca2+
homeostasis when [Ca2+]i is raised by
Ca2+ release. Although further effort is required to
completely elucidate mitochondrial contribution in Ca2+
regulation, the results described here may offer some insight in
Ca2+ homeostasis in arterial smooth muscle cells.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. Richard J. Evans (Department Cell Physiology and Pharmacology, University of Leicester) for help with the U tube superfusion system.
| |
FOOTNOTES |
|---|
This study was supported by British Heart Foundation Grant FS/2000001 and Wellcome Trust Grant 055506. T. Kamishima is a British Heart Foundation Intermediate Fellow.
Address for reprint requests and other correspondence: T. Kamishima, Dept. of Human Anatomy and Cell Biology, Univ. of Liverpool, The Sherrington Bldgs., Ashton St., Liverpool L69 3GE, UK (E-mail: kamishi{at}liv.ac.uk).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
July 26, 2002;10.1152/ajpheart.00865.2001
Received 1 October 2001; accepted in final form 19 July 2002.
| |
REFERENCES |
|---|
|
|
|---|
1.
Arnaudeau, S,
Kelley WL,
Walsh JVJ,
and
Demaurex N.
Mitochondria recycle Ca2+ to the endoplasmic reticulum and prevent the depletion of neighboring endoplasmic reticulum regions.
J Biol Chem
276:
29430-29439,
2001
2.
Babcock, DF,
Herrington J,
Goodwin PC,
Park YB,
and
Hille B.
Mitochondrial participation in the intracellular Ca2+ network.
J Cell Biol
136:
833-844,
1997
3.
Babenko, AP,
Aguilar-Bryan L,
and
Bryan J.
A view of SUR/KIR 6.X, KATP channels.
Annu Rev Physiol
60:
667-687,
1998[Web of Science][Medline].
4.
Bassani, JWM,
Bassani RA,
and
Bers DM.
Ca2+ cycling between sarcoplasmic reticulum and mitochondria in rabbit cardiac myocytes.
J Physiol
460:
603-621,
1993
5.
Budd, SL,
and
Nicholls DG.
A reevaluation of the role of mitochondria in neuronal Ca2+ homeostasis.
J Neurochem
66:
403-411,
1996[Web of Science][Medline].
6.
Drummond, RM,
and
Tuft RA.
Release of Ca2+ from the sarcoplasmic reticulum increases mitochondrial [Ca2+] in rat pulmonary artery smooth muscle cells.
J Physiol
516:
139-147,
1999
7.
Duchen, MR.
Contributions of mitochondria to animal physiology: from homeostatic sensor to calcium signalling and cell death.
J Physiol
516:
1-17,
1999
8.
Duchen, MR,
and
Biscoe TJ.
Relative mitochondrial membrane potential and [Ca2+]i in type I cells isolated from the rabbit carotid body.
J Physiol
450:
33-61,
1992
9.
Evans, RJ,
and
Kennedy C.
Characterization of P2-purinoceptors in the smooth muscle of the rat tail artery: a comparison between contractile and electrophysiological responses.
Br J Pharmacol
113:
853-860,
1994[Web of Science][Medline].
10.
Fleischmann, BK,
Murray RK,
and
Kotlikoff MI.
Voltage window for sustained elevation of cytosolic calcium in smooth muscle cells.
Proc Natl Acad Sci USA
91:
11914-11918,
1994
11.
Garlid, KD,
Paucek P,
Yarov-Yarovoy V,
Murray HN,
Darbenzio RB,
D'Alonzo AJ,
Lodge NJ,
Smith MA,
and
Grover GJ.
Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels: possible mechanism of cardioprotection.
Circ Res
81:
1072-1082,
1997
12.
Greenwood, IA,
Helliwell RM,
and
Large WA.
Modulation of Ca2+-activated Cl
currents in rabbit portal vein smooth muscle by an inhibitor of mitochondrial Ca2+ uptake.
J Physiol
505:
53-64,
1997
13.
Grimmsmann, T,
and
Rustenbeck I.
Direct effects of diazoxide on mitochondria in pancreatic B-cells and on isolated liver mitochondria.
Br J Pharmacol
123:
781-788,
1998[Web of Science][Medline].
14.
Gross, GJ,
and
Fryer RM.
Sarcolemmal versus mitochondrial ATP-sensitive K+ channels and myocardial preconditioning.
Circ Res
84:
973-979,
1999
15.
Grynkiewicz, G,
Poenie M,
and
Tsien RY.
A new generation of Ca2+ indicators with greatly improved fluorescence properties.
J Biol Chem
260:
3440-3450,
1985
16.
Hajnóczky, G,
Csordás G,
Madesh M,
and
Pacher P.
The machinery of local Ca2+ signalling between sarco-endoplasmic reticulum and mitochondria.
J Physiol
529:
69-81,
2000
17.
Hajnóczky, G,
Robb-Gaspers LD,
Seitz MB,
and
Thomas AP.
Decoding of cytosolic calcium oscillations in the mitochondria.
Cell
82:
415-424,
1995[Web of Science][Medline].
18.
Hamill, OP,
Marty A,
Neher E,
Sakmann B,
and
Sigworth FJ.
Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.
Pflügers Arch
391:
85-100,
1981[Web of Science][Medline].
19.
Holmuhamedov, EL,
Wang L,
and
Terzic A.
ATP-sensitive K+ channel openers prevent Ca2+ overload in rat cardiac mitochondria.
J Physiol
519:
347-360,
1999
20.
Hoth, M,
Fanger CM,
and
Lewis RS.
Mitochondrial regulation of store-operated calcium signaling in T lymphocytes.
J Cell Biol
137:
633-648,
1997
21.
Inoue, I,
Nagase H,
Kishi K,
and
Higuti T.
ATP-sensitive K+ channel in the mitochondrial inner membrane.
Nature
352:
244-247,
1991[Medline].
22.
Jouaville, LS,
Ichas F,
Holmuhamedov EL,
Camacho P,
and
Lechleiter JD.
Synchronization of calcium waves by mitochondrial substrates in Xenopus laevis oocytes.
Nature
377:
438-441,
1995[Medline].
23.
Kamishima, T,
Davies NW,
and
Standen NB.
Mechanisms that regulate [Ca2+]i following depolarization in rat systemic arterial smooth muscle cells.
J Physiol
522:
285-295,
2000
24.
Kamishima, T,
and
McCarron JG.
Depolarization-evoked increases in cytosolic calcium concentration in isolated smooth muscle cells of rat portal vein.
J Physiol
492:
61-74,
1996
25.
Kamishima, T,
and
McCarron JG.
Ca2+ removal mechanisms in rat cerebral resistance size arteries.
Biophys J
75:
1767-1773,
1998[Web of Science][Medline].
26.
Kamishima, T,
and
Quayle JM.
Possible interaction between mitochondria and sarcoplasmic reticulum in Ca2+ removal (Abstract).
Biophys J
80:
613A-614A,
2001.
27.
Kowaltowski, AJ,
Seetharaman S,
Paucek P,
and
Garlid KD.
Bioenergetic consequences of opening the ATP-sensitive K+ channel of heart mitochondria.
Am J Physiol Heart Circ Physiol
280:
H649-H657,
2001
28.
Liu, Y,
Sato T,
O'Rourke B,
and
Marban E.
Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection?
Circulation
97:
2463-2469,
1998
29.
McCarron, JG,
Crichton CA,
Langton PD,
MacKenzie A,
and
Smith GL.
Myogenic contraction by modulation of voltage-dependent calcium currents in isolated rat cerebral arteries.
J Physiol
498:
371-379,
1997
30.
McGeown, JG,
McCarron JG,
Drummond RM,
and
Fay FS.
Calcium-calmodulin-dependent mechanisms accelerate calcium decay in gastric myocytes from Bufo marinus.
J Physiol
506:
95-107,
1998
31.
Monteith, GR,
and
Blaustein MP.
Heterogeneity of mitochondrial matrix free Ca2+: resolution of Ca2+ dynamics in individual mitochondria in situ.
Am J Physiol Cell Physiol
276:
C1193-C1204,
1999
32.
Park, MK,
Ashby MC,
Erdemli G,
Petersen OH,
and
Tepikin AV.
Perinuclear, perigranular and sub-plasmalemmal mitochondria have distinct functions in the regulation of cellular calcium transport.
EMBO J
20:
1863-1874,
2001[Web of Science][Medline].
33.
Poenie, M,
Alderton J,
Steinhardt R,
and
Tsien R.
Calcium rises abruptly and briefly throughout the cell at the onset of anaphase.
Science
233:
886-889,
1986
34.
Rizzuto, R,
Bernardi P,
and
Pozzan T.
Mitochondria as all-round players of the calcium game.
J Physiol
529:
37-47,
2000
35.
Rizzuto, R,
Brini M,
Murgia M,
and
Pozzan T.
Microdomains with high Ca2+ close to IP3-sensitive channels that are sensed by neighboring mitochondria.
Science
262:
744-747,
1993
36.
Rizzuto, R,
Simpson AWM,
Brini M,
and
Pozzan T.
Rapid changes of mitochondrial Ca2+ revealed by specifically targeted recombinant aequorin.
Nature
358:
325-327,
1992[Medline].
37.
Steenbergen, JM,
and
Fay FS.
The quantal nature of calcium release to caffeine in single smooth muscle cells results from activation of the sarcoplasmic reticulum Ca2+-ATPase.
J Biol Chem
271:
1821-1824,
1996
This article has been cited by other articles:
![]() |
J. M. Quayle, M. R. Turner, H. E. Burrell, and T. Kamishima Effects of hypoxia, anoxia, and metabolic inhibitors on KATP channels in rat femoral artery myocytes Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H71 - H80. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-X. Zhang, X. Ma, W. Zhang, C.-K. Yeh, A. Lin, J. Luo, E. A. Sprague, R. H. Swerdlow, and M. S. Katz Polyunsaturated fatty acids mobilize intracellular Ca2+ in NT2 human teratocarcinoma cells by causing release of Ca2+ from mitochondria Am J Physiol Cell Physiol, May 1, 2006; 290(5): C1321 - C1333. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Laporte, A. Hui, and I. Laher Pharmacological Modulation of Sarcoplasmic Reticulum Function in Smooth Muscle Pharmacol. Rev., December 1, 2004; 56(4): 439 - 513. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kamishima and J. M. Quayle P2 receptor-mediated Ca2+ transients in rat cerebral artery smooth muscle cells Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H535 - H544. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |